Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma
Status:
Not yet recruiting
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of weight management plus megestrol acetate in obese patients
with early endometrioid carcinoma（EEC）asking for fertility-sparing treatment